• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用含有二硫键官能团的氨基甲酸酯连接链对固体载体进行衍生化。

Derivatization of Solid Supports Using a Carbamate-Linked Tether Containing a Disulfide Functional Group.

作者信息

Saraya Jagandeep S, O'Flaherty Derek K

机构信息

Department of Chemistry, University of Guelph, Guelph, Canada.

出版信息

Curr Protoc. 2025 Aug;5(8):e70174. doi: 10.1002/cpz1.70174.

DOI:10.1002/cpz1.70174
PMID:40773368
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12330986/
Abstract

Chemical modifications of oligonucleotides are widely used to improve their functional properties. Amino modifiers provide versatile chemical handles for post-synthetic (bio)conjugation, nucleic acid immobilization on solid supports, and studies of nonenzymatic genome replication related to the origins of life. This protocol describes an economical disulfide-containing solid-support linker that enables on-column synthesis of nucleic acids bearing 3'-amino or 3'-phosphate modifications. The orthogonal nature of this linker allows for an on-column protecting group strategy, facilitating the synthesis of DNA and RNA containing 3'-amino-2',3'-dideoxyribosides from commercially available unprotected mononucleosides. This protocol further extends the on-column construction of oligomers containing 3'-amino-2',3'-dideoxyribosides to those containing a 2'-amino-2'-deoxynucleoside at the 3'-end, using an orthogonal protecting group strategy. An improved on-column deprotection procedure for DNA and RNA is also presented, eliminating the precipitation step typically utilized in conventional RNA workflows, resulting in an enhanced strand recovery for certain sequences. Finally, the disulfide-containing solid support is applied to the preparation of amino acid-oligonucleotide conjugates, wherein the identity of the final product was contingent upon the specific deprotection conditions employed. All oligonucleotide conjugates and derivatives were purified using standard methods [(e.g., strong anion exchange high-performance liquid chromatography (SAX-HPLC)] and characterized by mass spectrometry (MS). © 2025 The Author(s). Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1: Synthesis of 4,4'-dimethoxytrityl (DMTr) disulfide succinimide and solid-support functionalization reaction Basic Protocol 2: Solid-phase synthesis of DNA containing a 3'-amino-2',3'-dideoxyguanosine using 3'-Disulfide CPG Alternate Protocol 1: Synthesis of DNA containing terminal 2'-amino-2'-deoxyadenosine Alternate Protocol 2: Alternate RNA (terminated with 3'-amino modifiers or phosphate) workflow using D-TentaGel Basic Protocol 3: Amino acid-oligonucleotide conjugate synthesis using Lys and D-TentaGel.

摘要

寡核苷酸的化学修饰被广泛用于改善其功能特性。氨基修饰剂为合成后(生物)共轭、核酸在固体支持物上的固定以及与生命起源相关的非酶促基因组复制研究提供了通用的化学处理方法。本方案描述了一种经济的含二硫键的固体支持物连接体,它能够在柱上合成带有3'-氨基或3'-磷酸修饰的核酸。这种连接体的正交性质允许采用柱上保护基策略,便于从市售的未保护单核苷合成含有3'-氨基-2',3'-二脱氧核糖核苷的DNA和RNA。本方案进一步将含有3'-氨基-2',3'-二脱氧核糖核苷的寡聚物的柱上构建扩展到那些在3'-末端含有2'-氨基-2'-脱氧核苷的寡聚物,采用正交保护基策略。还提出了一种改进的DNA和RNA柱上脱保护程序,消除了传统RNA工作流程中通常使用的沉淀步骤,从而提高了某些序列的链回收率。最后,将含二硫键的固体支持物应用于氨基酸 - 寡核苷酸共轭物的制备,其中最终产物的特性取决于所采用的特定脱保护条件。所有寡核苷酸共轭物和衍生物均使用标准方法[例如强阴离子交换高效液相色谱(SAX - HPLC)]进行纯化,并通过质谱(MS)进行表征。© 2025作者。由Wiley Periodicals LLC出版的《当前方案》。基本方案1:4,4'-二甲氧基三苯甲基(DMTr)二硫代琥珀酰亚胺的合成及固体支持物功能化反应 基本方案2:使用3'-二硫键控制孔玻璃(CPG)固相合成含有3'-氨基-2',3'-二脱氧鸟苷的DNA 替代方案1:合成含有末端2'-氨基-2'-脱氧腺苷的DNA 替代方案2:使用D - TentaGel的替代RNA(以3'-氨基修饰剂或磷酸终止)工作流程 基本方案3:使用赖氨酸和D - TentaGel合成氨基酸 - 寡核苷酸共轭物

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/12330986/de08a9376f8a/CPZ1-5-0-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/12330986/fc021f8ee49a/CPZ1-5-0-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/12330986/0aa27839dd55/CPZ1-5-0-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/12330986/1b0d46556bf9/CPZ1-5-0-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/12330986/f0cde7cf9863/CPZ1-5-0-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/12330986/cb03472a81d3/CPZ1-5-0-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/12330986/df658b0cd7b6/CPZ1-5-0-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/12330986/179e9cd42d75/CPZ1-5-0-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/12330986/102bcd775e8d/CPZ1-5-0-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/12330986/294af4d77ae4/CPZ1-5-0-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/12330986/dd3221ef556d/CPZ1-5-0-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/12330986/6b9d17701404/CPZ1-5-0-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/12330986/007f162602bc/CPZ1-5-0-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/12330986/5a93b4296b09/CPZ1-5-0-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/12330986/244b2d132ed1/CPZ1-5-0-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/12330986/0854b289fc55/CPZ1-5-0-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/12330986/22d304965feb/CPZ1-5-0-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/12330986/53fdc4ab15b3/CPZ1-5-0-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/12330986/9fa85a736645/CPZ1-5-0-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/12330986/a129eb63b61c/CPZ1-5-0-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/12330986/de08a9376f8a/CPZ1-5-0-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/12330986/fc021f8ee49a/CPZ1-5-0-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/12330986/0aa27839dd55/CPZ1-5-0-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/12330986/1b0d46556bf9/CPZ1-5-0-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/12330986/f0cde7cf9863/CPZ1-5-0-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/12330986/cb03472a81d3/CPZ1-5-0-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/12330986/df658b0cd7b6/CPZ1-5-0-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/12330986/179e9cd42d75/CPZ1-5-0-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/12330986/102bcd775e8d/CPZ1-5-0-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/12330986/294af4d77ae4/CPZ1-5-0-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/12330986/dd3221ef556d/CPZ1-5-0-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/12330986/6b9d17701404/CPZ1-5-0-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/12330986/007f162602bc/CPZ1-5-0-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/12330986/5a93b4296b09/CPZ1-5-0-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/12330986/244b2d132ed1/CPZ1-5-0-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/12330986/0854b289fc55/CPZ1-5-0-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/12330986/22d304965feb/CPZ1-5-0-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/12330986/53fdc4ab15b3/CPZ1-5-0-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/12330986/9fa85a736645/CPZ1-5-0-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/12330986/a129eb63b61c/CPZ1-5-0-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/12330986/de08a9376f8a/CPZ1-5-0-g004.jpg

相似文献

1
Derivatization of Solid Supports Using a Carbamate-Linked Tether Containing a Disulfide Functional Group.使用含有二硫键官能团的氨基甲酸酯连接链对固体载体进行衍生化。
Curr Protoc. 2025 Aug;5(8):e70174. doi: 10.1002/cpz1.70174.
2
An Aqueous-Compatible On-Column Approach for the Conjugation of Nucleic Acids Using Amino Modifiers.一种使用氨基修饰剂进行核酸偶联的水相兼容柱上方法。
Curr Protoc. 2025 Jul;5(7):e70169. doi: 10.1002/cpz1.70169.
3
A Versatile Disulfide-Containing Solid-Support Strategy for 3'-Modifiers in Oligonucleotides: Introducing Modular Tandem Oligonucleotide Synthesis.一种用于寡核苷酸3'修饰的通用含二硫键固相支持策略:引入模块化串联寡核苷酸合成
Chem Asian J. 2025 Aug;20(16):e00537. doi: 10.1002/asia.202500537. Epub 2025 Jun 2.
4
Phosphoramidite Platform for the Automated Synthesis of Morpholino Antisense Oligonucleotides and Their Chimeras.用于自动合成吗啉代反义寡核苷酸及其嵌合体的亚磷酰胺平台。
Curr Protoc. 2025 Jun;5(6):e70162. doi: 10.1002/cpz1.70162.
5
[Preparation and chromatographic performance evaluation of hydrophilic interaction chromatography stationary phase based on amino acids].基于氨基酸的亲水作用色谱固定相的制备及色谱性能评价
Se Pu. 2025 Jul;43(7):734-743. doi: 10.3724/SP.J.1123.2025.04015.
6
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.卡莫司汀植入剂与替莫唑胺治疗新诊断的高级别胶质瘤的有效性和成本效益:一项系统评价与经济学评估
Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450.
7
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
8
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
9
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
10
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.

本文引用的文献

1
A Versatile Disulfide-Containing Solid-Support Strategy for 3'-Modifiers in Oligonucleotides: Introducing Modular Tandem Oligonucleotide Synthesis.一种用于寡核苷酸3'修饰的通用含二硫键固相支持策略:引入模块化串联寡核苷酸合成
Chem Asian J. 2025 Aug;20(16):e00537. doi: 10.1002/asia.202500537. Epub 2025 Jun 2.
2
A Robust Strategy for Introducing Amino-Modifiers in Nucleic Acids: Enabling Novel Amino Tandem Oligonucleotide Synthesis in DNA and RNA.一种在核酸中引入氨基修饰剂的稳健策略:实现DNA和RNA中新型氨基串联寡核苷酸的合成。
Chemistry. 2025 May 8;31(26):e202500448. doi: 10.1002/chem.202500448. Epub 2025 Apr 17.
3
Aqueous Compatible Post-Synthetic On-Column Conjugation of Nucleic Acids Using Amino-Modifiers.
使用氨基修饰剂进行核酸的水相兼容合成后柱上共轭反应
Chembiochem. 2025 Jan 2;26(1):e202400643. doi: 10.1002/cbic.202400643. Epub 2024 Nov 13.
4
Manganese(II) promotes prebiotically plausible non-enzymatic RNA ligation reactions.锰(II)促进了具有前生物合理性的非酶 RNA 连接反应。
Chem Commun (Camb). 2024 Jun 20;60(51):6528-6531. doi: 10.1039/d4cc01086h.
5
Diversifying DNA-Tagged Amines by Isocyanide Multicomponent Reactions for DNA-Encoded Library Synthesis.通过异腈多组分反应实现DNA标记胺的多样化用于DNA编码文库合成
ACS Omega. 2024 Feb 7;9(7):7719-7724. doi: 10.1021/acsomega.3c07136. eCollection 2024 Feb 20.
6
Chemistry, structure and function of approved oligonucleotide therapeutics.已获批的寡核苷酸治疗药物的化学、结构和功能。
Nucleic Acids Res. 2023 Apr 11;51(6):2529-2573. doi: 10.1093/nar/gkad067.
7
Evaluation of 3'-phosphate as a transient protecting group for controlled enzymatic synthesis of DNA and XNA oligonucleotides.评估3'-磷酸作为用于DNA和XNA寡核苷酸可控酶促合成的瞬态保护基团。
Commun Chem. 2022 Jun 1;5(1):68. doi: 10.1038/s42004-022-00685-5.
8
Disulfide based prodrugs for cancer therapy.用于癌症治疗的基于二硫键的前药。
RSC Adv. 2020 Jun 25;10(41):24397-24409. doi: 10.1039/d0ra04155f. eCollection 2020 Jun 24.
9
Chemistry of Peptide-Oligonucleotide Conjugates: A Review.肽核酸缀合物的化学:综述。
Molecules. 2021 Sep 6;26(17):5420. doi: 10.3390/molecules26175420.
10
Application of l-Threonine Aldolase to on-DNA Reactions.L-苏氨酸醛缩酶在DNA上反应中的应用。
Bioconjug Chem. 2021 Sep 15;32(9):1973-1978. doi: 10.1021/acs.bioconjchem.1c00363. Epub 2021 Aug 23.